Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$31.15 - $33.39 $16,914 - $18,130
543 Added 1.0%
54,697 $1.82 Million
Q3 2022

Nov 01, 2022

BUY
$30.9 - $33.55 $341,723 - $371,029
11,059 Added 25.66%
54,154 $1.71 Million
Q2 2022

Aug 12, 2022

BUY
$23.75 - $31.69 $1.02 Million - $1.37 Million
43,095 New
43,095 $1.31 Million
Q2 2022

Aug 09, 2022

SELL
$23.75 - $31.69 $885,613 - $1.18 Million
-37,289 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$19.97 - $26.94 $16,015 - $21,605
-802 Reduced 2.11%
37,289 $994,000
Q2 2021

Aug 11, 2021

BUY
$18.01 - $28.32 $630 - $991
35 Added 0.09%
38,091 $844,000
Q1 2021

May 17, 2021

SELL
$19.76 - $29.89 $72,282 - $109,337
-3,658 Reduced 8.77%
38,056 $998,000
Q4 2020

Feb 16, 2021

SELL
$15.73 - $21.66 $106,853 - $147,136
-6,793 Reduced 14.0%
41,714 $780,000
Q3 2020

Nov 17, 2020

BUY
$13.54 - $26.41 $624,166 - $1.22 Million
46,098 Added 1913.57%
48,507 $823,000
Q3 2020

Nov 13, 2020

SELL
$13.54 - $26.41 $687,317 - $1.34 Million
-50,762 Reduced 95.47%
2,409 $40,000
Q2 2020

Aug 17, 2020

BUY
$7.84 - $23.29 $2,187 - $6,497
279 Added 0.53%
53,171 $1.24 Million
Q4 2019

Feb 11, 2020

BUY
$7.9 - $10.14 $417,846 - $536,324
52,892 New
52,892 $516,000
Q3 2019

Oct 25, 2019

SELL
$9.17 - $12.01 $514,657 - $674,049
-56,124 Closed
0 $0
Q2 2019

Jul 31, 2019

SELL
$10.88 - $17.6 $10,107 - $16,350
-929 Reduced 1.63%
56,124 $0
Q4 2018

Feb 12, 2019

SELL
$14.52 - $19.72 $12,051 - $16,367
-830 Reduced 1.43%
57,053 $915,000
Q3 2018

Nov 13, 2018

BUY
$14.85 - $16.35 $861 - $948
58 Added 0.1%
57,883 $859,000
Q2 2018

Aug 10, 2018

SELL
$13.8 - $16.8 $220 - $268
-16 Reduced 0.03%
57,825 $919,000
Q1 2018

May 10, 2018

BUY
$13.8 - $16.2 $20,451 - $24,008
1,482 Added 2.63%
57,841 $821,000
Q4 2017

Feb 09, 2018

SELL
$13.55 - $15.8 $66,787 - $77,878
-4,929 Reduced 8.04%
56,359 $789,000
Q3 2017

Nov 09, 2017

BUY
$13.45 - $14.35 $824,323 - $879,482
61,288
61,288 $867,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.